Grand Pharmaceutical Group Ltd (STU:MX6A)
€ 0.525 0 (0%) Market Cap: 1.94 Bil Enterprise Value: 2.20 Bil PE Ratio: 6.71 PB Ratio: 1.03 GF Score: 97/100

Telix Pharmaceuticals Ltd Grand Pharma Investor Webinar Transcript

Apr 20, 2023 / 02:00AM GMT
Release Date Price: €0.535
David N. Cade
Telix Pharmaceuticals Limited - CEO of Asia Pacific

Good morning, everybody, and welcome to all of the audience. We are coming to you from Singapore. I'd like to extend a very warm welcome on behalf of Telix Leadership and the China Grand Pharma Leadership to this morning's investor webinar on the opportunity for radiopharmaceuticals in China.

Just a couple of messages I've been asked to pass on before we start. First of all, questions, we will hold till the end. And those who would like to ask a question can file a DM to the moderator, which is available down the bottom of the screen. And secondly, those who are listening in, who are native Chinese speakers or Mandarin speakers, there is a separate channel, which is accessible at the bottom of the Zoom screen as well.

Please read our -- next slide, please read our respective company disclaimers. Next slide, I think today, we have a very interesting agenda for the event. I'll introduce the co-speakers in a moment. We're going to start by just reviewing the Telix-Grand Pharma partnership, which is now 2.5 years mature. We

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot